These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25163440)

  • 1. Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial.
    Farokhnia M; Shafiee Sabet M; Iranpour N; Gougol A; Yekehtaz H; Alimardani R; Farsad F; Kamalipour M; Akhondzadeh S
    Hum Psychopharmacol; 2014 Jul; 29(4):351-9. PubMed ID: 25163440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.
    Akhondzadeh S; Sabet MS; Harirchian MH; Togha M; Cheraghmakani H; Razeghi S; Hejazi SSh; Yousefi MH; Alimardani R; Jamshidi A; Zare F; Moradi A
    J Clin Pharm Ther; 2010 Oct; 35(5):581-8. PubMed ID: 20831681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
    Noorbala AA; Akhondzadeh S; Tahmacebi-Pour N; Jamshidi AH
    J Ethnopharmacol; 2005 Feb; 97(2):281-4. PubMed ID: 15707766
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    D'Onofrio G; Nabavi SM; Sancarlo D; Greco A; Pieretti S
    Curr Neuropharmacol; 2021; 19(9):1606-1616. PubMed ID: 33441068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
    Mecocci P; Bladström A; Stender K
    Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs.
    Avgerinos KI; Vrysis C; Chaitidis N; Kolotsiou K; Myserlis PG; Kapogiannis D
    Neurol Sci; 2020 Oct; 41(10):2747-2754. PubMed ID: 32445136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine.
    Doody RS; Geldmacher DS; Farlow MR; Sun Y; Moline M; Mackell J
    Dement Geriatr Cogn Disord; 2012; 33(2-3):164-73. PubMed ID: 22572767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.
    Agha-Hosseini M; Kashani L; Aleyaseen A; Ghoreishi A; Rahmanpour H; Zarrinara AR; Akhondzadeh S
    BJOG; 2008 Mar; 115(4):515-9. PubMed ID: 18271889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
    Akhondzadeh S; Tahmacebi-Pour N; Noorbala AA; Amini H; Fallah-Pour H; Jamshidi AH; Khani M
    Phytother Res; 2005 Feb; 19(2):148-51. PubMed ID: 15852492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.
    Shahmansouri N; Farokhnia M; Abbasi SH; Kassaian SE; Noorbala Tafti AA; Gougol A; Yekehtaz H; Forghani S; Mahmoodian M; Saroukhani S; Arjmandi-Beglar A; Akhondzadeh S
    J Affect Disord; 2014 Feb; 155():216-22. PubMed ID: 24289892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
    Wilkinson D; Andersen HF
    Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):369-74. PubMed ID: 19751915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response.
    Wilkinson D; Wirth Y; Goebel C
    Dement Geriatr Cogn Disord; 2014; 37(1-2):71-85. PubMed ID: 24107324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression.
    Akhondzadeh S; Mostafavi SA; Keshavarz SA; Mohammadi MR; Hosseini S; Eshraghian MR
    J Clin Pharm Ther; 2020 Feb; 45(1):134-143. PubMed ID: 31602695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial.
    Moazen-Zadeh E; Abbasi SH; Safi-Aghdam H; Shahmansouri N; Arjmandi-Beglar A; Hajhosseinn Talasaz A; Salehiomran A; Forghani S; Akhondzadeh S
    J Altern Complement Med; 2018 Apr; 24(4):361-368. PubMed ID: 29185780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease.
    Jones RW; Bayer A; Inglis F; Barker A; Phul R
    Int J Geriatr Psychiatry; 2007 Mar; 22(3):258-62. PubMed ID: 17243195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
    Cumbo E; Ligori LD
    J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial.
    Schulz JB; Rainer M; Klünemann HH; Kurz A; Wolf S; Sternberg K; Tennigkeit F
    J Alzheimers Dis; 2011; 25(3):463-75. PubMed ID: 21471647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials.
    Winblad B; Jones RW; Wirth Y; Stöffler A; Möbius HJ
    Dement Geriatr Cogn Disord; 2007; 24(1):20-7. PubMed ID: 17496417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.